<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40320950</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2386-5857</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias</Title><ISOAbbreviation>Emergencias</ISOAbbreviation></Journal><ArticleTitle>Antiviral prescription of mild to moderate COVID-19 and adherence to official recommendations in Spanish emergency departments.</ArticleTitle><Pagination><StartPage>95</StartPage><EndPage>102</EndPage><MedlinePgn>95-102</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.55633/s3me/016.2025</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To analyze the prescription of antiviral therapy for mild to moderate COVID-19 in Spanish emergency departments, the incidence of missed opportunities to prescribe, and associated factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective cross-sectional study in 16 hospital emergency departments. We collected data for adults with mild to moderate COVID-19 confirmed within 7 days of first symptoms. The patients studied were at risk for progression and were treated as outpatients during the first 8 months of 2022. We estimated the incidence of missed opportunities and evaluated associated factors with a Bayesian statistical approach assuming noninformative prior distributions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The overall incidence of missed opportunities to prescribe was 33.5% (95% probability interval [PI], 31.7%- 35.3%). Incidences in the 16 hospitals ranged from 17.8% to 50.6%. Adjusted odds ratios (aORs) showed that factors associated with more missed opportunities were age (aOR, 1.021; 95% PI, 1.013-1.029); widening of recommended indications relative to the first period (aOR third period, 2.641 [95% PI, 1.844-3.783]; aOR fourth period, 7.440 [95% PI, 5.352-10.343]; and aOR fifth period, 17.743 [95% PI, 10.821-29.105]); immunosuppression (aOR, 2.698; 95% PI, 2.115-3.443); and fewer vaccine doses relative to no vaccination (aOR 3 doses, 0.287 [95% PI, 0.197-0-417] and aOR 4 doses, 0.115 [95% PI, 0.074-0.179]). Factors associated with increased antiviral prescription were obesity (aOR, 0.735, 95% PI, 0.567-0.952) and the existence of automated clinical pathway alerts (aOR, 0.287; 95% PI, 0.114-0.721).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The incidence of missed opportunities to prescribe antiviral therapy is high. Incidences vary across hospitals and more often involve the most vulnerable patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Leal</LastName><ForeName>Crist&#xf3;bal M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3;n para la Investigaci&#xf3;n e Innovaci&#xf3;n Biom&#xe9;dica del Hospital Universitario Infanta Sof&#xed;a y Hospital Universitario del Henares, Madrid, Espa&#xf1;a. Facultad de Estudios Estad&#xed;sticos, Universidad Complutense de Madrid (UCM), Madrid, Espa&#xf1;a. Servicio de Urgencias, Hospital Universitario del Henares, Coslada, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez Del Castillo</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, IdISCC, Hospital Cl&#xed;nico San Carlos, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llorens</LastName><ForeName>Pere</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Unidad de Corta Estancia y Hospitalizaci&#xf3;n a Domicilio, Hospital General Dr. Balmis, Alicante, Instituto de Investigaci&#xf3;n Sanitaria y Biom&#xe9;dica de Alicante (ISABIAL), Universidad Miguel Hern&#xe1;ndez, Alicante, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oteo Mata</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, IdISCC, Hospital Cl&#xed;nico San Carlos, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales Franco</LastName><ForeName>Bel&#xe9;n</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital de la Vega Lorenzo Guirao, Cieza, Murcia, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moya Olmeda</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Virgen de la Luz, Cuenca, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortiz Garc&#xed;a</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Santa B&#xe1;rbara, Soria, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salmer&#xf3;n B&#xe9;liz</LastName><ForeName>Octavio Jos&#xe9;</ForeName><Initials>OJ</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario Fundaci&#xf3;n Alcorc&#xf3;n, Alcorc&#xf3;n, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pons Frigola</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario y Polit&#xe9;cnico La Fe, Valencia, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Rio Navarro</LastName><ForeName>Rigoberto Jes&#xfa;s</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario Doctor Peset, Valencia, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez Faya</LastName><ForeName>Hugo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario de Navarra, Pamplona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rom&#xe1;n</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Unidad de Corta Estancia y Hospitalizaci&#xf3;n a Domicilio, Hospital General Dr. Balmis, Alicante, Instituto de Investigaci&#xf3;n Sanitaria y Biom&#xe9;dica de Alicante (ISABIAL), Universidad Miguel Hern&#xe1;ndez, Alicante, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valle Borrego</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario Severo Ochoa, Legan&#xe9;s, Madrid. Universidad Alfonso X El Sabio, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;n-Quir&#xf3;s</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario La Paz - IDIPAZ, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villena Garc&#xed;a Del Real</LastName><ForeName>Henrique</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Cl&#xed;nico Universitario de Santiago de Compostela, Universidad de Santiago de Compostela, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavasci L&#xf3;pez</LastName><ForeName>Ivana Ver&#xf3;nica</ForeName><Initials>IV</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Virgen de Altagracia, Manzanares, Ciudad Real, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez Moreno</LastName><ForeName>Mar&#xed;a Teresa</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Cl&#xed;nico Universitario de Valencia, Valencia, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gayoso Mart&#xed;n</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario El Escorial, El Escorial, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz Grinspan</LastName><ForeName>Mart&#xed;n Sebasti&#xe1;n</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario del Henares, Coslada, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez P&#xe9;rez</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Facultad de Estudios Estad&#xed;sticos, Universidad Complutense de Madrid (UCM), Madrid, Espa&#xf1;a. Instituto de Estad&#xed;stica y Ciencia de Datos. UCM, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Susi Garc&#xed;a</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Facultad de Estudios Estad&#xed;sticos, Universidad Complutense de Madrid (UCM), Madrid, Espa&#xf1;a. Instituto de Estad&#xed;stica y Ciencia de Datos. UCM, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Grupo de estudio COVID CODE SPAIN</CollectiveName></Author></AuthorList><Language>spa</Language><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><VernacularTitle>Uso de antivirales para el tratamiento de la COVID-19 leve-moderada y seguimiento de las recomendaciones oficiales en los servicios de urgencias hospitalarios espa&#xf1;oles.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Emergencias</MedlineTA><NlmUniqueID>9805751</NlmUniqueID><ISSNLinking>1137-6821</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="Y">Emergency Service, Hospital</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="Y">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="Y">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019983" MajorTopicYN="Y">Guideline Adherence</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="Y">Practice Patterns, Physicians'</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011307" MajorTopicYN="N">Drug Prescriptions</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">Analizar el uso de los antivirales frente a la COVID-19 leve-moderada en los servicios de urgencias hospitalarios (SUH) espa&#xf1;oles, la incidencia de p&#xe9;rdida de oportunidad en su prescripci&#xf3;n y factores asociados.</AbstractText><AbstractText Label="METODO" NlmCategory="METHODS">Se realiz&#xf3; un estudio transversal retrospectivo en 16 SUH espa&#xf1;oles. Se recogieron pacientes adultos con COVID-19 leve-moderado sintom&#xe1;tico confirmado en los primeros 7 d&#xed;as de s&#xed;ntomas, con factores de riesgo de progresi&#xf3;n, decisi&#xf3;n de manejo ambulatorio y atendidos durante los primeros 8 meses de 2022. Se estim&#xf3; la incidencia de p&#xe9;rdida de oportunidad y factores asociados mediante metodolog&#xed;a bayesiana asumiendo distribuciones de probabilidad a priori no informativas.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">La incidencia global de p&#xe9;rdida de oportunidad fue del 33,5% (intervalo de probabilidad al 95% &#x2013;IP 95%&#x2013;, 31,7-35,3), la cual oscil&#xf3; entre centros desde el 17,8% hasta el 50,6%. La edad (odds ratio ajustado &#x2013;ORa&#x2013;1,021, IP 95% 1,013-1,029), una indicaci&#xf3;n m&#xe1;s amplia respecto al primer periodo de referencia (ORa tercero 2,641, IP 95% 1,844-3,783; ORa cuarto 7,440, IP 95% 5,352-10,343; ORa quinto 17,743, IP 95% 10,821-29,105), la inmunosupresi&#xf3;n (ORa 2,698, IP 95% 2,115-3,443) y un menor n&#xfa;mero de dosis de vacunas (no vacunado referencia; ORa 3 dosis 0,287, IP 95% 0,197-0,417; ORa 4 dosis 0,115, IP 95% 0,074-0,179) se asociaron con una mayor p&#xe9;rdida de oportunidad; en tanto que la obesidad (ORa 0,735, IP 95% 0,567-0,952) y la existencia de una v&#xed;a cl&#xed;nica automatizada (ORa 0,287, IP 95% 0,114-0,721) se asociaron con una mayor prescripci&#xf3;n.</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="CONCLUSIONS">La incidencia de p&#xe9;rdida de oportunidad en el tratamiento del COVID-19 es elevada, afecta de forma heterog&#xe9;nea a los centros y lo hace de forma m&#xe1;s intensa en los pacientes m&#xe1;s vulnerables.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Emergency department</Keyword><Keyword MajorTopicYN="N">Gu&#xed;as cl&#xed;nicas</Keyword><Keyword MajorTopicYN="N">Molnupiravir</Keyword><Keyword MajorTopicYN="N">Nirmatrelvir</Keyword><Keyword MajorTopicYN="N">Practice Guidelines</Keyword><Keyword MajorTopicYN="N">Remdesivir</Keyword><Keyword MajorTopicYN="N">Servicio de urgencia hospitalario</Keyword><Keyword MajorTopicYN="N">Sotrovimab</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>5</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>5</Day><Hour>3</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40320950</ArticleId><ArticleId IdType="doi">10.55633/s3me/016.2025</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>